You just read:

BioDelivery Sciences Announces Presentation of Data on the Impact of a State Formulary Conversion to BUNAVAIL® at the International Conference on Opioids

News provided by

BioDelivery Sciences International, Inc.

Jun 06, 2016, 07:00 ET